About Cobalt Oak
Specialist intelligence for regulated AI clinical software.
Cobalt Oak is a focused intelligence platform for investors assessing AI clinical software startups and scaleups where regulatory maturity, clinical evidence, and execution risk matter.
What we do
We structure company signals that general databases often leave fragmented.
Cobalt Oak organizes public information on AI clinical software startups and scaleups into structured company profiles. The platform focuses on regulatory profile, clinical evidence maturity, market positioning, growth stage, and strategic relevance.
The goal is not to cover every AI company or every digital health company. The focus is intentionally narrow: regulated AI clinical software, where the path from product promise to real-world adoption depends on evidence, compliance, and execution.
Why it exists
AI clinical software needs a different intelligence layer.
Generalist databases are broad.
They help identify companies, funding events, and categories, but often lack depth on regulatory and clinical evidence signals.
Regulated software is different.
In AI clinical software, regulatory pathway, intended use, validation evidence, and market readiness directly shape execution risk.
Investors need structured signals.
Cobalt Oak helps users screen companies through a focused lens combining regulatory, clinical, market, and strategic relevance indicators.
Focus
Built for investors looking at a specific category of health technology.
Cobalt Oak focuses on AI clinical software startups and scaleups, including companies operating in diagnostic AI, clinical decision support, risk prediction, triage, imaging AI, workflow AI, remote monitoring, and related regulated software categories.
This focus allows the platform to go beyond simple company discovery and support a more strategic view of company maturity, evidence visibility, and regulatory relevance.
Methodology
Public signals, structured into comparable company profiles.
Regulatory signal
Regulatory profile, CE/FDA visibility, medical software relevance, and available public regulatory information.
Clinical evidence signal
Published evidence, clinical validation visibility, evidence maturity, clinical area, and source availability.
Market signal
Geography, segment, company stage, financing visibility, operational status, and venture relevance.
Strategic relevance
Structured interpretation of how company signals may matter for screening, comparison, and deeper diligence.
Sources
Built from public information, not private company claims.
Cobalt Oak uses publicly available sources such as company websites, product pages, regulatory databases, clinical publications, market references, and other public materials.
Company profiles are updated as new public signals are identified. Users can also suggest company updates when information appears incomplete, outdated, or inaccurate.
Explore the Cobalt Platform.
Screen AI clinical software startups and scaleups through structured regulatory, clinical, market, and strategic relevance signals.
Explore the PlatformCobalt Oak provides strategic intelligence based on publicly available information. It does not provide investment, legal, regulatory, or medical advice.